The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer

Clinical trial NCT04991129 · TERMINATED

Trial details

NCT number: NCT04991129
Sponsor: Suzhou Junjing BioSciences Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hematologic Malignancies Advanced Solid Tumors

Start date: 2021-09-10
Primary completion: 2025-05-28
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.